newsfilter
← Latest News
PR Newswire·

INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...